Can Basilea’s Antibiotic Succeed Where Others Have Failed?

Company Looks To Partner Ceftobiprole Ahead Of US Approval

 
• By Alaric DeArment
  
Basilea announced Phase III results in serious Staphylococcus aureus infections • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business